Showing results (151-160 of 510) with videos related to
Sort By:
Pageof 51
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2020
Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic CancerValeria Merz, Camilla Zecchetto, Raffaela Santoro, et al.Annals of Surgical Oncology|March 8, 2012
Telomere-specific reverse transcriptase (hTERT) and cell-free RNA in plasma as predictors of pathologic tumor response in rectal cancer patients receiving neoadjuvant chemoradiotherapySalvatore Pucciarelli, Enrica Rampazzo, Marta Briarava, et al.Medical Oncology (Northwood, London, England)|February 2, 2021
Extensive molecular reclassification: new perspectives in small bowel adenocarcinoma?Andrea Casadei-Gardini, Sara Lonardi, Valeria Smiroldo, et al.Cancers|April 12, 2022
Impact of Positive Radial Margin on Recurrence and Survival in Perihilar CholangiocarcinomaFrancesco Enrico D'Amico, Claudia Mescoli, Silvia Caregari, et al.Annals of Surgical Oncology|March 19, 2011
Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapyMarco Agostini, Salvatore Pucciarelli, Maria Vittoria Enzo, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 20, 2019
Capecitabine in advanced hepatocellular carcinoma: A multicenter experienceFilippo Pelizzaro, Ambra Sammarco, Vincenzo Dadduzio, et al.Updates in Surgery|October 22, 2022
ctDNA as promising tool for the assessment of minimal residual disease (MRD) and the need of an adjuvant treatment in gastroesophageal adenocarcinomaVittoria Matilde Piva, Maria Caterina De Grandis, Irene Sole Zuin, et al.Cancers|November 11, 2022
Impact of Microscopic Confirmation on Therapeutic Management of Pancreatic Cancer Patients: Lessons from an Italian Regional Tumor RegistryAlberto Fantin, Mario Gruppo, Ottavia De Simoni, et al.The Oncologist|August 19, 2018
Another Chapter of the Right Versus Left Story: Is Primary Tumor Location a Prognostic Feature in RAS Mutant Metastatic Colorectal Cancer?Fotios Loupakis, Marta Schirripa, Rossana Intini, et al.Journal of Clinical Medicine|July 27, 2024
Short- and Long-Term Outcomes in Elderly Patients with Resectable Esophageal Cancer: Upfront Esophagectomy Compared to Surgery after Neoadjuvant TreatmentsLucia Moletta, Elisa Sefora Pierobon, Giovanni Capovilla, et al.Pageof 51